Encube Ethicals is a finished-dose manufacturer based in India. It appears in 58 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with US FDA, EDE (AE) and CDSCO (India). Its GMP standing is certified by EMA, US FDA and ANVISA (Brazil). Its most recent recorded inspection, by US FDA, closed on 23 January 2025 as NAI. Customs aggregates show $102.1M of exports covering 1,786 molecules to 30 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Ponda, United Arab Emirates | Not on file |
| PONDÁ, India | Not on file |
| Ponda, India | 3005669319 |
| Durham, United States | 3015216825 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| US FDA | 36 | 2 |
| EDE (AE) | 13 | None |
| CDSCO (India) | 2 | None |
| UZPHARM (UZ) | 2 | None |
| ARCSA (EC) | 1 | None |
| NCELS (KZ) | 1 | None |
| EMA | None | 2 |
| ANVISA (Brazil) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $16.4M | 22 |
| 2025 | Not reported | $102.1M | 30 |
| 2024 | Not reported | $70.1M | 24 |
| 2023 | Not reported | $60.0M | 30 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Encube Ethicals comes back tiered against every other supplier able to file there.
Start for free